COVID-19 IgM Lateral Flow Assay
Hoʻolauna Huahana
ʻO Virusee® COVID-19 IgM Lateral Flow Assay kahi immunoassay kahe lateral i hoʻohana ʻia no ka ʻike qualitative o Novel Coronavirus IgM antibody i loko o ke koko holoʻokoʻa / serum / plasma samples in vitro.Hoʻohana nui ʻia ia i ka maʻi maʻi maʻi kōkua o ka pneumonia coronavirus novel.
ʻO ka novel coronavirus kahi maʻi RNA stranded hoʻokahi.ʻAʻole like me ka coronavirus i ʻike ʻia, ʻoi aku ka maʻalahi o ka heluna kanaka no ka Novel Coronavirus, a ʻoi aku ka hoʻoweliweli ʻana i ka poʻe ʻelemakule a i ʻole ka poʻe me nā maʻi kumu.ʻO IgM antibodies maikaʻi kahi hōʻailona koʻikoʻi o nā maʻi coronavirus hou.ʻO ka ʻike ʻana i nā antibodies kikoʻī coronavirus hou e kōkua i ka maʻi maʻi.
Nā hiʻohiʻona
| inoa | COVID-19 IgM Lateral Flow Assay |
| Kaʻina hana | Lateral Flow Assay |
| ʻAno laʻana | Koko, plasma, serum |
| Hōʻike | 40 hōʻike / pahu |
| Ka manawa ʻike | 10 min |
| Nā mea ʻike | COVID-19 |
| Paʻa | Paʻa ka pahu no 1 makahiki ma 2-30 ° C |
Pōmaikaʻi
- wikiwiki
Loaʻa ka hopena i loko o 10 min - Maʻalahi
ʻIke ʻia ka hopena heluhelu, maʻalahi ke wehewehe
Kaʻina hana maʻalahi, me ka ʻole o ka hana paʻakikī
- Mālama i ke kumu kūʻai
Hiki ke lawe ʻia a mālama ʻia ka huahana ma ka lumi wela, e hōʻemi ana i nā kumukūʻai - pilikia haʻahaʻa
Ke hoʻāʻo ʻana i ka laʻana koko, e hōʻemi ana i ka pilikia o ke kaʻina hana laʻana - He kūpono no ka nānā ʻana ma ka pūnaewele, ʻaoʻao moe, outpatient
Ke kumu a me ke kumu
Ua puka mai ʻo SARS-CoV-2 ma ke ʻano he virus novel me ka loaʻa ʻole o kahi koho lapaʻau a ua hoʻokau i kahi pōʻino koʻikoʻi ma ka honua holoʻokoʻa.ʻO ka maʻi i hoʻokumu ʻia e kēia maʻi, "COVID-19", hoʻolaha i kahi maʻi maʻi honua ma Malaki 11, 2020. Me ka loaʻa ʻole o ka lāʻau lapaʻau kūpono a me ka lāʻau lapaʻau no COVID-19, ke ʻike nei ka poʻe a puni ka honua i kahi pōpilikia honua e pili ana i nā hui āpau, a ʻo ia hoʻi. ua hoʻouna aku i nā piliona kānaka i ka laka.Ma ka honua holoʻokoʻa, ke hoʻomaka nei nā hoʻoikaika ikaika e pale i kēia maʻi maʻi ʻoiai ua hopena ia i ka hāʻule ʻana o nā ʻōnaehana olakino a ua hoʻomaka i nā loli geopolitical a me ka hoʻokele waiwai.
ʻO ka maʻi maikaʻi ʻole o ka COVID-19 ua hāʻawi pū i ka nui o ka maʻi ma muli o ke koʻikoʻi (i ka hihia o ka maikaʻi ʻole) a me ka laha ʻana o ka maʻi (inā he hewa hoʻopunipuni).ʻO ka nele o ka hōʻike hōʻike RT-PCR o nā ʻāpana hanu haʻahaʻa ke kumu nui o ka kuhi hewa ʻana o nā maʻi maʻi maʻi he COVID-19 a ʻaʻole paha.Hōʻike ʻia kahi maʻi wikiwiki me ka hoʻāʻo serological i nā hiʻohiʻona SARS-CoV-2 IgG/IgM i kahi ala ʻoi aku ka maikaʻi o ka seroconversion.
He mea koʻikoʻi ka IgG/IgM e ʻike i ka lōʻihi a me ke kumu o nā pane ʻakaʻaka kūʻē iā SARS-CoV-2, a hiki ke ʻike ʻia kēia mau antibodies mai kekahi mau lā ma hope o ka hoʻomaka ʻana o nā maʻi a hiki ke noho i ke kino ma hope o nā makahiki o ka maʻi. .I ka hihia o COVID-19, hiki ke ʻike ʻia ka pane ʻana o IgM a me IgG mai ka pule ʻelua o ka maʻi.
Hāʻawi nā serologic assays i ka diagnostic wikiwiki ma o ka pale ʻana i ka PCR hoʻopunipuni maikaʻi ʻole a i ʻole nā hopena hoʻopunipuni a hāʻawi pū kēia i ke ʻano antibody no ka manaʻo ʻana i ka ikaika a me ka lōʻihi o ka palekana humoral.
Hiki i ka ʻike antibody IgM a me IgG ke ʻike i nā hihia i manaʻo ʻia me nā hoʻokolohua nucleic acid maikaʻi ʻole.Ke hoʻohālikelike ʻia me ka ʻike ʻana i ka waikawa nucleic, hiki i ka ʻike ʻana o IgM a me IgG ke hāʻawi i kahi ala ʻike wikiwiki, maʻalahi, a pololei hoʻi no nā hihia i manaʻo ʻia he COVID-19.
Kaʻina hoʻāʻo
ʻIke Kauoha
| Hoʻohālike | wehewehe | Code huahana |
| VMLFA-01 | 40 hoʻāʻo/kit, ʻano hoʻopaʻa | CoVMLFA-01 |
